Evernest Financial Advisors, LLC Nexgel, Inc. Transaction History
Evernest Financial Advisors, LLC
- $275 Million
- Q2 2025
A detailed history of Evernest Financial Advisors, LLC transactions in Nexgel, Inc. stock. As of the latest transaction made, Evernest Financial Advisors, LLC holds 281,000 shares of NXGL stock, worth $755,890. This represents 0.26% of its overall portfolio holdings.
Number of Shares
281,000
Previous 224,666
25.07%
Holding current value
$755,890
Previous $669,000
8.22%
% of portfolio
0.26%
Previous 0.26%
Shares
2 transactions
Others Institutions Holding NXGL
# of Institutions
18Shares Held
696KCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY87.8KShares$236,1920.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny81.6KShares$219,5870.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA68.7KShares$184,6680.0% of portfolio
-
Geode Capital Management, LLC Boston, MA66.4KShares$178,5320.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA38.5KShares$103,4540.03% of portfolio
About NEXGEL, INC.
- Ticker NXGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 5,572,230
- Market Cap $15M
- Description
- NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was...